Evidence 1
Activity
Activity
0% Hemolysis
Toxicity
125.0 µg/mL
Hemolytic
Cytotoxic
0% Hemolysis | 125.0 | µg/mL | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. | J Biol Chem | 2005